These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10599691)

  • 1. Gigantism.
    Eugster EA; Pescovitz OH
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4379-84. PubMed ID: 10599691
    [No Abstract]   [Full Text] [Related]  

  • 2. Overgrowth. Hormonal Causes.
    Sotos JF
    Clin Pediatr (Phila); 1996 Nov; 35(11):579-90. PubMed ID: 8953133
    [No Abstract]   [Full Text] [Related]  

  • 3. Five-year follow-up of a 13-year-old boy with a pituitary adenoma causing gigantism--effect of octreotide therapy.
    Schoof E; Dörr HG; Kiess W; Lüdecke DK; Freitag E; Zindel V; Rascher W; Dötsch J
    Horm Res; 2004; 61(4):184-9. PubMed ID: 14739526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gs alpha mutation at codon 201 in pituitary adenoma causing gigantism in a 6-year-old boy with McCune-Albright syndrome.
    Dötsch J; Kiess W; Hänze J; Repp R; Lüdecke D; Blum WF; Rascher W
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3839-42. PubMed ID: 8923825
    [No Abstract]   [Full Text] [Related]  

  • 5. Congenital gigantism due to growth hormone-releasing hormone excess and pituitary hyperplasia with adenomatous transformation.
    Zimmerman D; Young WF; Ebersold MJ; Scheithauer BW; Kovacs K; Horvath E; Whitaker MD; Eberhardt NL; Downs TR; Frohman LA
    J Clin Endocrinol Metab; 1993 Jan; 76(1):216-22. PubMed ID: 8421089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterozygous gsp mutation renders ion channels of human somatotroph adenoma cells unresponsive to growth hormone-releasing hormone.
    Yasufuku-Takano J; Takano K; Takei T; Fukumoto S; Teramoto A; Takakura K; Yamashita N; Fujita T
    Endocrinology; 1999 May; 140(5):2018-26. PubMed ID: 10218950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pituitary gigantism.
    Daughaday WH
    Endocrinol Metab Clin North Am; 1992 Sep; 21(3):633-47. PubMed ID: 1521516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary hyperplasia and gigantism in mice caused by a cholera toxin transgene.
    Burton FH; Hasel KW; Bloom FE; Sutcliffe JG
    Nature; 1991 Mar; 350(6313):74-7. PubMed ID: 1848356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pituitary gigantism].
    Tanaka T
    Nihon Rinsho; 2006 May; Suppl 1():139-42. PubMed ID: 16776112
    [No Abstract]   [Full Text] [Related]  

  • 10. Growth hormone-releasing hormone resistance in pseudohypoparathyroidism type ia: new evidence for imprinting of the Gs alpha gene.
    Mantovani G; Maghnie M; Weber G; De Menis E; Brunelli V; Cappa M; Loli P; Beck-Peccoz P; Spada A
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4070-4. PubMed ID: 12970263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone-releasing hormone and pituitary somatotrope proliferation.
    Frohman LA; Kineman RD
    Minerva Endocrinol; 2002 Dec; 27(4):277-85. PubMed ID: 12511850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of endogenous growth hormone-releasing hormone in acromegaly.
    Dimaraki EV; Chandler WF; Brown MB; Jaffe CA; Kim SY; Taussig R; Padmanabhan V; Barkan AL
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2185-90. PubMed ID: 16537684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevant cAMP-specific phosphodiesterase isoforms in human pituitary: effect of Gs(alpha) mutations.
    Persani L; Borgato S; Lania A; Filopanti M; Mantovani G; Conti M; Spada A
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3795-800. PubMed ID: 11502813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutively active Gs alpha is associated with an increased phosphodiesterase activity in human growth hormone-secreting adenomas.
    Lania A; Persani L; Ballaré E; Mantovani S; Losa M; Spada A
    J Clin Endocrinol Metab; 1998 May; 83(5):1624-8. PubMed ID: 9589667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of Albright's hereditary osteodystrophy-like syndrome complicated by several endocrinopathies: normal Gs alpha gene and chromosome 2q37.
    Sakaguchi H; Sanke T; Ohagi S; Iiri T; Nanjo K
    J Clin Endocrinol Metab; 1998 May; 83(5):1563-5. PubMed ID: 9589656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical usefulness of growth hormone secretion elicited by acute stimulation tests.
    Audí L; Carrascosa A
    Clin Endocrinol (Oxf); 2013 Aug; 79(2):168-9. PubMed ID: 23442210
    [No Abstract]   [Full Text] [Related]  

  • 17. Expression of cyclic adenosine 3',5'-monophosphate (cAMP)-responsive element binding protein and inducible-cAMP early repressor genes in growth hormone-secreting pituitary adenomas with or without mutations of the Gsalpha gene.
    Peri A; Conforti B; Baglioni-Peri S; Luciani P; Cioppi F; Buci L; Corbetta S; Ballaré E; Serio M; Spada A
    J Clin Endocrinol Metab; 2001 May; 86(5):2111-7. PubMed ID: 11344215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis: pituitary gigantism in a 2 1/2-year old child.
    Bhowmick SK; Rettig KR
    Clin Pediatr (Phila); 2008 Sep; 47(7):708-10. PubMed ID: 18724405
    [No Abstract]   [Full Text] [Related]  

  • 19. The gsalpha gene: predominant maternal origin of transcription in human thyroid gland and gonads.
    Mantovani G; Ballare E; Giammona E; Beck-Peccoz P; Spada A
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4736-40. PubMed ID: 12364467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of growth hormone secretion after testosterone treatment in boys with constitutional delay of growth and adolescence: evidence against an increase in hypothalamic secretion of growth hormone-releasing hormone.
    Racine MS; Symons KV; Foster CM; Barkan AL
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3326-31. PubMed ID: 15240610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.